JP2006525299A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525299A5
JP2006525299A5 JP2006506208A JP2006506208A JP2006525299A5 JP 2006525299 A5 JP2006525299 A5 JP 2006525299A5 JP 2006506208 A JP2006506208 A JP 2006506208A JP 2006506208 A JP2006506208 A JP 2006506208A JP 2006525299 A5 JP2006525299 A5 JP 2006525299A5
Authority
JP
Japan
Prior art keywords
azetidine
alkyl
pharmaceutical composition
aryl
carboxamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006506208A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525299A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2004/001884 external-priority patent/WO2004096794A1/en
Publication of JP2006525299A publication Critical patent/JP2006525299A/ja
Publication of JP2006525299A5 publication Critical patent/JP2006525299A5/ja
Pending legal-status Critical Current

Links

JP2006506208A 2003-05-01 2004-04-29 アゼチジンカルボキサミド誘導体及びcb1レセプター媒介障害の治療におけるその使用 Pending JP2006525299A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0310052 2003-05-01
PCT/GB2004/001884 WO2004096794A1 (en) 2003-05-01 2004-04-29 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs

Publications (2)

Publication Number Publication Date
JP2006525299A JP2006525299A (ja) 2006-11-09
JP2006525299A5 true JP2006525299A5 (https=) 2007-06-21

Family

ID=33397040

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006506208A Pending JP2006525299A (ja) 2003-05-01 2004-04-29 アゼチジンカルボキサミド誘導体及びcb1レセプター媒介障害の治療におけるその使用

Country Status (4)

Country Link
US (2) US20070173486A1 (https=)
EP (1) EP1618105A1 (https=)
JP (1) JP2006525299A (https=)
WO (1) WO2004096794A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004252109B2 (en) 2003-06-11 2010-04-08 Merck Sharp & Dohme Corp. Substituted 3-alkyl and 3-alkenyl azetidine derivatives
US20060025448A1 (en) 2004-07-22 2006-02-02 Cadila Healthcare Limited Hair growth stimulators
US7906652B2 (en) 2005-11-28 2011-03-15 Merck Sharp & Dohme Corp. Heterocycle-substituted 3-alkyl azetidine derivatives
JP2010500300A (ja) 2006-08-08 2010-01-07 サノフィ−アベンティス アリールアミノアリール−アルキル−置換イミダゾリジン−2,4−ジオン、それらの製造法、それらの化合物を含有する薬剤、およびそれらの使用
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
JP5033736B2 (ja) 2008-08-08 2012-09-26 株式会社小松製作所 排気ガス浄化装置
JP5079630B2 (ja) 2008-08-08 2012-11-21 株式会社小松製作所 排気ガス浄化装置
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
MX2012001729A (es) 2009-08-26 2012-06-13 Sanofi Sa Nuevos hidratos cristalinos de fluoroglicosido heteroaromatico, productos farmaceuticos que comprenden estos compuestos, y su empleo.
WO2011157827A1 (de) 2010-06-18 2011-12-22 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2683698B1 (de) 2011-03-08 2017-10-04 Sanofi Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683705B1 (de) 2011-03-08 2015-04-22 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2683702B1 (de) 2011-03-08 2014-12-24 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683701B1 (de) 2011-03-08 2014-12-24 Sanofi Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120052A1 (de) 2011-03-08 2012-09-13 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2683699B1 (de) 2011-03-08 2015-06-24 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2671870A1 (en) * 2012-06-05 2013-12-11 Bioprojet Novel (aza)benzhydryl ether derivatives, their process of preparation and their use as H4-receptor ligands for therapeutical applications
US11141404B1 (en) 2020-11-18 2021-10-12 Anebulo Pharmaceuticals, Inc. Formulations and methods for treating acute cannabinoid overdose
AU2022362107A1 (en) 2021-10-11 2024-05-02 Anebulo Pharmaceuticals, Inc. Crystalline forms of a cannabinoid receptor type 1 (cb1) modulator and methods of use and preparation thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU39992B (en) * 1976-04-02 1985-06-30 Janssen Pharmaceutica Nv Process for obtaining new piperazine and piperidine derivatives
US4261990A (en) * 1979-03-09 1981-04-14 Ciba-Geigy Corporation N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics
JPH03264562A (ja) * 1989-05-22 1991-11-25 Hokuriku Seiyaku Co Ltd ピペリジン誘導体
CA2015949A1 (en) * 1989-05-22 1990-11-22 Yasuo Ito Piperidine derivative, method for preparation thereof, and a pharmaceutical composition comprising the same
JPH09278737A (ja) * 1996-02-16 1997-10-28 Tanabe Seiyaku Co Ltd フェノール誘導体及びその製法
JP3194355B2 (ja) * 1996-10-24 2001-07-30 宇部興産株式会社 ピペリジン化合物及びその製法
CA2285264A1 (en) * 1997-04-25 1998-11-05 Michiyo Gyoten Condensed pyridazine derivatives, their production and use
DE69911373T2 (de) * 1998-01-23 2004-07-01 Vernalis Research Ltd., Winnersh Azetidincarboxamidderivate zur behandlung von zns-erkrankungen
CN1149214C (zh) * 1998-12-04 2004-05-12 东丽株式会社 三唑并衍生物和含有它们作为有效组分的趋化因子抑制剂
GB9917386D0 (en) * 1999-07-23 1999-09-22 Cerebrus Ltd Chemical compounds-II
AU2002347906A2 (en) * 2001-10-16 2003-04-28 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators

Similar Documents

Publication Publication Date Title
JP2006525299A5 (https=)
RU2595902C2 (ru) Замещенные бензамидные производные
AU2012313254B8 (en) Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
RU2569887C2 (ru) Производные оксазолинов для лечения расстройств цнс
US20040152754A1 (en) Cyclic AMP-specific phosphodiesterase inhibitors
CN1440402A (zh) 作为趋化因子受体活性调节剂的n-脲基杂环烷基-哌啶
JP2006525298A5 (https=)
JP2013516415A5 (https=)
RU2011115111A (ru) Замещенные пирролидин-2-карбоксамиды
JP2005526723A5 (https=)
WO2007052843A1 (ja) 複素環アミド化合物およびその用途
CN107001259B (zh) 作为taar配体的取代的氮杂环丁烷衍生物
JP2017524026A5 (https=)
RU2009138219A (ru) Новые бензамидные производные и способ их получения
CN104024250A (zh) 作为痕量胺相关受体(taar)的杂环衍生物
JP6186495B2 (ja) Cetp抑制活性を有する新規なオキサゾリジノン誘導体、その製造方法およびこれを含む薬学組成物
RU2625798C2 (ru) Производные (3-метилпирролидин-3-ил)-метил пиридинилового эфира и их применение в качестве антагонистов рецептора nk-3
JP5677457B2 (ja) ピロリジン誘導体
RU2690154C2 (ru) Производные морфолин-пиридина
JP5410536B2 (ja) 3−(ベンジルアミノ)−ピロリジン誘導体及びnk−3受容体アンタゴニストとしてのその使用
JP2011524397A (ja) Nk受容体アンタゴニストとしてのピロリジン誘導体
RU2006135486A (ru) Производные n-пиперидина в качестве модуляторов ссr3
WO2009104729A1 (ja) アミド誘導体及びそれを含有する医薬組成物
JP2011529871A (ja) チオフェン−2−カルボキサミド誘導体、これらの調製およびこれらの治療的使用
JP2010514824A (ja) 置換n−(4−シアノ−1h−ピラゾール−3−イル)メチルアミン誘導体、これらの調製およびこれらの治療的使用